OrbusNeich is leading the way in the development of Pro-Healing technologies for the treatment of coronary artery disease.
OrbusNeich is a global company that designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. Current products are the world’s first dual therapy stent, COMBO™ Dual Therapy Stent and the world’s first pro-healing stent, Genous™ Bio-engineered Cobalt Chromium stent, as well as stents and balloons marketed under the names of Azule™, Scoreflex™, Sapphire™, Sapphire™ NC, Sapphire™ II, Sapphire™ II PRO and Sapphire II NC™. OrbusNeich is headquartered in Hong Kong and has operations in Fort Lauderdale, Florida, USA.; Hoevelaken, the Netherlands; and Shenzhen, China. OrbusNeich supplies products today to interventional cardiologists in more than 60 countries.